SCM
Sarissa Capital Management’s Vor Biopharma VOR Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $823K | Hold |
508,016
| – | – | 0.53% | 7 |
|
2025
Q1 | $365K | Sell |
508,016
-109,984
| -18% | -$78.9K | 0.24% | 7 |
|
2024
Q4 | $686K | Hold |
618,000
| – | – | 0.21% | 8 |
|
2024
Q3 | $433K | Hold |
618,000
| – | – | 0.11% | 9 |
|
2024
Q2 | $618K | Hold |
618,000
| – | – | 0.1% | 9 |
|
2024
Q1 | $1.46M | Hold |
618,000
| – | – | 0.26% | 9 |
|
2023
Q4 | $1.39M | Hold |
618,000
| – | – | 0.21% | 8 |
|
2023
Q3 | $1.31M | Hold |
618,000
| – | – | 0.18% | 9 |
|
2023
Q2 | $1.91M | Hold |
618,000
| – | – | 0.19% | 10 |
|
2023
Q1 | $3.32M | Hold |
618,000
| – | – | 0.43% | 9 |
|
2022
Q4 | $4.11M | Hold |
618,000
| – | – | 0.49% | 9 |
|
2022
Q3 | $2.46M | Hold |
618,000
| – | – | 0.28% | 9 |
|
2022
Q2 | $3.07M | Sell |
618,000
-89,010
| -13% | -$442K | 0.31% | 9 |
|
2022
Q1 | $4.27M | Hold |
707,010
| – | – | 0.4% | 9 |
|
2021
Q4 | $8.22M | Hold |
707,010
| – | – | 0.71% | 9 |
|
2021
Q3 | $11.1M | Hold |
707,010
| – | – | 0.87% | 9 |
|
2021
Q2 | $13.2M | Hold |
707,010
| – | – | 1.05% | 9 |
|
2021
Q1 | $30.5M | Buy |
+707,010
| New | +$30.5M | 2.92% | 9 |
|